CD274 and hepatocellular carcinoma: Strikingly, tumors with high exosomal Lnc-CCNH-8 expression exhibit increased sensitivity to anti-PD-L1 monoclonal antibody therapy, underscoring its potential as a predictive immunotherapy response biomarker in HCC [147].